Why is Torrent Pharma falling/rising?

As of 07-Jul, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,340.00, reflecting a decrease of 28.0 points or 0.83%. The stock has underperformed its sector by 0.75% today and has traded within a narrow range of Rs 30.95. In terms of returns, the stock has shown a 1-week decline of 2.04% while it has performed positively over the past month with an increase of 5.99%. Despite this recent downturn, the company has demonstrated strong fundamentals, including a high return on capital employed (ROCE) of 22.33% and a low debt to EBITDA ratio of 1.26 times. Additionally, it has reported positive results for the last seven consecutive quarters, which supports its valuation.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has only declined by 0.20% over the past week. This indicates that while Torrent Pharmaceuticals has faced a more significant short-term setback, it has still managed to outperform the benchmark over longer periods, with a 15.63% return in the last year compared to the Sensex's 4.31%. However, a notable decline in investor participation, with a 58.86% drop in delivery volume against the 5-day average, may be contributing to the stock's current price movement. The high institutional holdings at 24.66% suggest that informed investors are still backing the company, which could stabilize the stock in the future.